(Q36406459)

14 August 2017

1 reference

title

The utility of magnetic resonance imaging in cardiac tissue regeneration trials (English)

1 reference

14 August 2017

author

Valentín Fuster Carulla

series ordinal

1

1 reference

14 August 2017

Javier Sanz

2

1 reference

14 August 2017

Juan F Viles-Gonzalez

series ordinal

3

1 reference

14 August 2017

Sanjay Rajagopalan

series ordinal

4

1 reference

14 August 2017

publication date

1 March 2006

1 reference

Nature Clinical Practice Cardiovascular Medicine

14 August 2017

published in

1 reference

14 August 2017

volume

3 Suppl 1

1 reference

14 August 2017

page(s)

S2-7

1 reference

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Prognosis in congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing β-Blocker Therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution T1-201 tomography and dobutamine stress echocardiography

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Fundamental concepts in myocardial viability assessment revisited: when knowing how much is "alive" is not enough

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Quantification of myocardial perfusion with FAST sequence and Gd bolus in patients with normal cardiac function

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Susceptibility-sensitive magnetic resonance imaging detects human myocardium supplied by a stenotic coronary artery without a contrast agent

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0418

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0418

1 reference

14 August 2017

1 reference